Amgen
Venture Capital
Amgen Ventures is the corporate venture capital arm of Amgen Inc., launched in 2004 with an initial $100 million commitment to fund early-stage biotechnology and human-therapeutics companies. Focus areas include oncology, inflammation, cardiovascular disease, and neuroscience; it has invested in more than 70 companies and now manages roughly $400 million.
Thousand Oaks, United States · 58+ investments
Early Stage
Seed
Growth
Late Stage
Pre-Seed
Biotech
Digital Health
biotechnology
healthcare IT
life sciences
therapeutics
Healthcare
Life Sciences
Oncology
Medtech
Immunology
- Headquarters
- Thousand Oaks, United States
- Founded
- 2004
- Website
- amgen.com
- AUM
- $200.0M
- Total Investments
- 58
- Last Investment
- May 2026
- Geographic Focus
- United States, Europe
Investment Thesis
Corporate venture arm investing in early-stage biotech, therapeutics, digital health, healthcare, life sciences, and oncology.
Amgen is a Venture Capital firm based in Thousand Oaks, United States. It has made 58 investments in Biotech and Digital Health.
Related Funds
Investment History
Sign up to view investment history
Create a free account — 10 credits a month to unlock deal history, amounts, and round details.